Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin Combined With Progestin for Atypical Endometrial Hyperplasia and Early-Stage Endometrial Carcinoma
NCT07890064Phase 2Not yet recruiting
- Start
- Jan 2027
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
A Phase 2 trial of canagliflozin in Atypical endometrial hyperplasia (AEH), Endometrioid endometrial carcinoma (EEC). Planned start Jan 2027; status: not yet recruiting.
02
Drugs
canagliflozin
03
Conditions
Atypical endometrial hyperplasia (AEH)Endometrioid endometrial carcinoma (EEC)
Beyond the preview
Go deeper on NCT07890064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07890064.